News

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to buy according to billionaires. Some experts view medical, healthcare ...
The Dow Jones Industrial Average is declining Wednesday morning with shares of Amgen and Merck seeing the biggest losses for the price-weighted average. Supported by world-class markets data from ...
Pfizer and AbbVie shares declined more than 4%, Merck dropped almost 4%, and Eli Lilly pulled back over 3% in early trading. Daily Merck & Company, Inc. Dow pharmaceutical components are leading ...
Let's take a look at what these Wall Street heavyweights have to say about Merck (MRK) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.
Step back from the mul­ti­tude of de­tails that go in­to every big phar­ma pipeline, and you’ll see the in­flu­ence that block­busters have on the en­tire … ...
With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimicotinib, paying Abbisko Therapeutics $85 million to secure the global license to the drug. The German pharma ...
RAHWAY, N.J., April 01, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2025 sales and earnings conference call with ...
We will always give you the option to opt out of our marketing. The Court of Appeal has upheld a lower court ruling between two pharmaceutical companies over the use of the word ‘Merck’, finding that ...
The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so conclusive that the company not only halted the study for efficacy ...
Merck (MRK) announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR compared to placebo in adults with pulmonary arterial hypertension WHO functional class ...